Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 4/2009

01-04-2009 | original article

A Critical Analysis of the Surgical Management of Early-Stage Gallbladder Cancer in the United States

Authors: Eric H. Jensen, Anasooya Abraham, Elizabeth B. Habermann, Waddah B. Al-Refaie, Selwyn M. Vickers, Beth A. Virnig, Todd M. Tuttle

Published in: Journal of Gastrointestinal Surgery | Issue 4/2009

Login to get access

Abstract

Background

Radical resection is recommended for selected patients with gallbladder (GB) cancer. We sought to determine whether radical resection improves survival for patients with early-stage cancer and to evaluate surgeon compliance with current treatment recommendations.

Patients and methods

Patients with stage 0, I, or II GB cancer who underwent surgical resection were identified from the Surveillance, Epidemiology, and End Results (SEER) tumor registry from 1988 through 2004. Patients were classified by surgical procedure performed (simple vs. radical resection) and adjuvant treatment given (radiation therapy [RT] vs. no RT). Unadjusted and adjusted overall survival (OS) and cancer-specific survival (CSS) were compared.

Results

Of the 4,631 patients who underwent surgery for early-stage GB cancer from 1988 through 2004, 4,188 (90.4%) underwent cholecystectomy alone and 443 (9.6%) underwent radical surgery including hepatic resection. The proportion of patients having radical surgery for T1b, T2, and T3 cancers was 4.5%, 5.6%, and 16.3%, respectively. For patients with T1b/T2 cancer, radical resection was associated with significant improvement in adjusted CSS (p = 0.01) and OS (p = 0.03). For patients with T3 cancers, we noted no improvement in CSS or OS. Survival for patients with node-positive disease (stage 2b) was universally poor and not improved by radical resection. For all patients who underwent radical resection, node negativity, female sex, age <70, low grade, and RT predicted improved CSS and OS.

Conclusions

Despite a significant survival advantage for patients with T1b/T2 GB cancer who undergo radical resection, this treatment is significantly underutilized. Ensuring delivery of recommended surgical treatment is vital to improving outcomes for patients with this disease.
Literature
1.
go back to reference Surveillance Epidemiology, End Results (SEER) Program. (http://www.seer.cancer.gov) Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. Surveillance Epidemiology, End Results (SEER) Program. (http://​www.​seer.​cancer.​gov) Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
2.
go back to reference Benson AB, 3rd, Bekaii-Saab T, Ben-Josef E, et al. Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Netw 2006; 4(8):728-50. Benson AB, 3rd, Bekaii-Saab T, Ben-Josef E, et al. Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Netw 2006; 4(8):728-50.
3.
go back to reference Fong Y, Malhotra S. Gallbladder cancer: recent advances and current guidelines for surgical therapy. Adv Surg 2001;35:1–20.PubMed Fong Y, Malhotra S. Gallbladder cancer: recent advances and current guidelines for surgical therapy. Adv Surg 2001;35:1–20.PubMed
9.
go back to reference Wise PE, Shi YY, Washington MK, et al. Radical resection improves survival for patients with pT2 gallbladder carcinoma. Am Surg. 2001;67(11):1041–1047.PubMed Wise PE, Shi YY, Washington MK, et al. Radical resection improves survival for patients with pT2 gallbladder carcinoma. Am Surg. 2001;67(11):1041–1047.PubMed
11.
12.
go back to reference Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 2007;96(1):8–13. doi:10.1002/jso.20831.PubMedCrossRef Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 2007;96(1):8–13. doi:10.​1002/​jso.​20831.PubMedCrossRef
13.
go back to reference Kresl JJ, Schild SE, Henning GT, et al. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002;52(1):167–175. doi:10.1016/S0360-3016(01)01764-3.PubMed Kresl JJ, Schild SE, Henning GT, et al. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002;52(1):167–175. doi:10.​1016/​S0360-3016(01)01764-3.PubMed
Metadata
Title
A Critical Analysis of the Surgical Management of Early-Stage Gallbladder Cancer in the United States
Authors
Eric H. Jensen
Anasooya Abraham
Elizabeth B. Habermann
Waddah B. Al-Refaie
Selwyn M. Vickers
Beth A. Virnig
Todd M. Tuttle
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 4/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-008-0772-8

Other articles of this Issue 4/2009

Journal of Gastrointestinal Surgery 4/2009 Go to the issue